IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: Europe/Mideast

Lonza and Teva discontinue biosimilars joint venture

7:16 AM MDT | August 23, 2013 | —Deepti Ramesh

Lonza and Teva Pharmaceutical Industries say that, following a strategic review, they have decided to discontinue their collaboration for the development, manufacturing, and marketing of biosimilars. Lonza and Teva established the biosimilars joint venture in 2009. Biosimilars are approved versions of innovator biopharmaceutical products, made after the innovator product’s patent...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa